title: Propofol-induced bradycardia in a pediatric patient undergoing chemotherapy with the known cardiotoxic agent cytarabin.
authors.forename: Samuel E
authors.initials: SE
authors.lastname: Wilson
authors.forename: Darren A
authors.initials: DA
authors.lastname: Boyack
authors.forename: Ogelue C
authors.initials: OC
authors.lastname: Ezeife-Ugorji
authors.forename: Andrew T
authors.initials: AT
authors.lastname: Costarino
mesh_terms: D018686:Anesthetics, Intravenous / Q000009:adverse effects*; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D001919:Bradycardia / Q000139:chemically induced*; D003561:Cytarabine / Q000009:adverse effects*; D004357:Drug Synergism; D006801:Humans; D007223:Infant; D008297:Male; D015742:Propofol / Q000009:adverse effects*
chemical_list: D018686:Anesthetics, Intravenous; D000964:Antimetabolites, Antineoplastic; D003561:Cytarabine; D015742:Propofol